MOTS-c 20mg
€ 99,00
MOTS-c 20 mg – Grail Formula Quality.
Independently verified to exceed 99 percent purity.
Validated for identity, structural integrity and stability.
Supplied as a 20 mg lyophilized peptide with full quality verification.
Within Europe this product is supplied including bacteriostatic water; outside the EU only the peptide vial is provided.
For research use only — not for human or veterinary use.
Availability: In stock: ships within 1 day after payment confirmation.
Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.
For research use only – not for human or veterinary use.
Product Overview
MOTS-c is a mitochondria-associated research peptide studied for its relevance to metabolic-regulation modelling, cellular-signalling analysis and structure–function behaviour in controlled in-vitro environments. This lyophilized 20 mg preparation supports reproducible evaluation of mechanistic pathways involving mitochondrial communication and regulated biochemical responses.
Peptide Overview
Research into mitochondrial-derived peptides expanded significantly between 2000 and 2015, leading to growing interest in MOTS-c as laboratories investigated its role in intracellular communication models.
From 2015 to 2025 MOTS-c became a central reference compound for studies examining metabolic flexibility, signalling-pathway modulation and cross-talk between mitochondrial and cellular regulatory systems. Its defined structure and consistent analytical profile make it suitable for advanced mechanistic research frameworks.
Historical Background and Scientific Context
During the early 2000s foundational work established new methodologies for studying mitochondria-derived peptides within biochemical regulation pathways.
Between 2010 and 2020 interest increased in metabolic-regulatory sequences capable of providing reproducible data in controlled in-vitro environments. MOTS-c became widely incorporated into signalling-pathway models aimed at analysing intracellular communication, metabolic adaptation and coordinated molecular responses.
Between 2020 and 2025 the peptide continued to serve as a reliable structural reference for comparative metabolic modelling and pathway-level evaluation.
Mechanistic Focus in Research
- Metabolic-regulation modelling and pathway-level evaluation
- Mitochondrial-signalling analysis in controlled in-vitro systems
- Structure–function assessment of mitochondria-associated peptides
- Comparative biochemical-modelling studies
- Investigation of intracellular response dynamics and communication pathways
Quality Verification
All Grail Formula research peptides are independently verified to exceed 99 percent purity. Each vial is evaluated for identity, structural integrity and stability using validated laboratory methodologies, ensuring reproducible behaviour across repeated analytical models.
When You Choose Grail Formula…
Researchers receive high-purity peptides with verified identity, sealed-vial integrity and purity exceeding 99 percent. EU shipments include sterile bacteriostatic water; outside Europe only the peptide vial is supplied.
For research use only – not for human or veterinary use.
- Independently verified to exceed 99 percent purity
- Validated for identity, structural integrity and stability
- High-quality mitochondrial-signalling research peptide
- Consistent analytical behaviour for metabolic-modelling studies
- EU shipments include bacteriostatic water
- For research use only – not for human or veterinary use
For laboratory research only. Not intended for human consumption, injection, or cosmetic use.
This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.
